1f86

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="1f86" size="450" color="white" frame="true" align="right" spinBox="true" caption="1f86, resolution 1.1&Aring;" /> '''TRANSTHYRETIN THR119...)
Line 1: Line 1:
-
[[Image:1f86.gif|left|200px]]<br />
+
[[Image:1f86.gif|left|200px]]<br /><applet load="1f86" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="1f86" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="1f86, resolution 1.1&Aring;" />
caption="1f86, resolution 1.1&Aring;" />
'''TRANSTHYRETIN THR119MET PROTEIN STABILISATION'''<br />
'''TRANSTHYRETIN THR119MET PROTEIN STABILISATION'''<br />
==Overview==
==Overview==
-
Transthyretin (TTR) amyloidosis is a conformational disturbance, which, like other amyloidoses, represents a life threat. Here, we report a TTR, variant, TTR Thr119Met, that has been shown to have a protective role in, the development of clinical symptoms in carriers of TTR Val30Met, one of, the most frequent variants among TTR amyloidosis patients. In order to, understand this effect, we have determined the structures of the TTR, Val30Met/Thr119Met double mutant isolated from the serum of one patient, and of both the native and thyroxine complex of TTR Thr119Met. Major, conclusions are: (i) new H-bonds within each monomer and monomer-monomer, inter-subunit contacts, e.g. Ser117-Ser117 and Met119-Tyr114, increase, protein stability, possibly leading to the protective effect of the TTR, Val30Met/Thr119Met variant when compared to the single variant TTR, Val30Met. (ii) The mutated residue (Met119) extends across the thyroxine, binding channel inducing conformational changes that lead to closer, contacts between different dimers within the tetramer. The data, at atomic, resolution, were essential to detect, for the first time, the subtle, changes in the inter-subunit contacts of TTR, and explain the, non-amyloidogenic potential of the TTR Thr119Met variant, improving, considerably current research on the TTR amyloid fibril formation pathway.
+
Transthyretin (TTR) amyloidosis is a conformational disturbance, which, like other amyloidoses, represents a life threat. Here, we report a TTR variant, TTR Thr119Met, that has been shown to have a protective role in the development of clinical symptoms in carriers of TTR Val30Met, one of the most frequent variants among TTR amyloidosis patients. In order to understand this effect, we have determined the structures of the TTR Val30Met/Thr119Met double mutant isolated from the serum of one patient and of both the native and thyroxine complex of TTR Thr119Met. Major conclusions are: (i) new H-bonds within each monomer and monomer-monomer inter-subunit contacts, e.g. Ser117-Ser117 and Met119-Tyr114, increase protein stability, possibly leading to the protective effect of the TTR Val30Met/Thr119Met variant when compared to the single variant TTR Val30Met. (ii) The mutated residue (Met119) extends across the thyroxine binding channel inducing conformational changes that lead to closer contacts between different dimers within the tetramer. The data, at atomic resolution, were essential to detect, for the first time, the subtle changes in the inter-subunit contacts of TTR, and explain the non-amyloidogenic potential of the TTR Thr119Met variant, improving considerably current research on the TTR amyloid fibril formation pathway.
==Disease==
==Disease==
Line 11: Line 10:
==About this Structure==
==About this Structure==
-
1F86 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with T44 as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1F86 OCA].
+
1F86 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=T44:'>T44</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1F86 OCA].
==Reference==
==Reference==
Line 17: Line 16:
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Single protein]]
[[Category: Single protein]]
-
[[Category: Sebastiao, M.P.]]
+
[[Category: Sebastiao, M P.]]
[[Category: T44]]
[[Category: T44]]
[[Category: amyloidogenesis]]
[[Category: amyloidogenesis]]
Line 24: Line 23:
[[Category: x-ray crystal structure]]
[[Category: x-ray crystal structure]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 16:50:00 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 12:35:55 2008''

Revision as of 10:35, 21 February 2008


1f86, resolution 1.1Å

Drag the structure with the mouse to rotate

TRANSTHYRETIN THR119MET PROTEIN STABILISATION

Contents

Overview

Transthyretin (TTR) amyloidosis is a conformational disturbance, which, like other amyloidoses, represents a life threat. Here, we report a TTR variant, TTR Thr119Met, that has been shown to have a protective role in the development of clinical symptoms in carriers of TTR Val30Met, one of the most frequent variants among TTR amyloidosis patients. In order to understand this effect, we have determined the structures of the TTR Val30Met/Thr119Met double mutant isolated from the serum of one patient and of both the native and thyroxine complex of TTR Thr119Met. Major conclusions are: (i) new H-bonds within each monomer and monomer-monomer inter-subunit contacts, e.g. Ser117-Ser117 and Met119-Tyr114, increase protein stability, possibly leading to the protective effect of the TTR Val30Met/Thr119Met variant when compared to the single variant TTR Val30Met. (ii) The mutated residue (Met119) extends across the thyroxine binding channel inducing conformational changes that lead to closer contacts between different dimers within the tetramer. The data, at atomic resolution, were essential to detect, for the first time, the subtle changes in the inter-subunit contacts of TTR, and explain the non-amyloidogenic potential of the TTR Thr119Met variant, improving considerably current research on the TTR amyloid fibril formation pathway.

Disease

Known diseases associated with this structure: Amyloid neuropathy, familial, several allelic types OMIM:[176300], Amyloidosis, senile systemic OMIM:[176300], Carpal tunnel syndrome, familial OMIM:[176300], Dystransthyretinemic hyperthyroxinemia OMIM:[176300]

About this Structure

1F86 is a Single protein structure of sequence from Homo sapiens with as ligand. Full crystallographic information is available from OCA.

Reference

Transthyretin stability as a key factor in amyloidogenesis: X-ray analysis at atomic resolution., Sebastiao MP, Lamzin V, Saraiva MJ, Damas AM, J Mol Biol. 2001 Mar 2;306(4):733-44. PMID:11243784

Page seeded by OCA on Thu Feb 21 12:35:55 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools